TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring Study

Area of Science:

• Pharmacokinetics and Drug Metabolism
• In Vitro Modeling and Simulation
• Gastrointestinal Physiology

Background:

• Biorelevant in vitro dissolution testing is crucial for predicting oral bioavailability but faces adoption barriers due to a lack of standardized validation for non-compendial systems.
• While the physiological relevance of TIM-1 and tiny-TIM gastrointestinal models is known, their inter-laboratory reproducibility has not been systematically assessed.
• This study addresses the need for standardized validation by evaluating the reproducibility of TIM systems in simulating gastrointestinal transit and drug absorption.

Purpose of the Study:

• To evaluate the inter-laboratory reproducibility of the tiny-TIM and TIM-1 in vitro gastrointestinal models.
• To assess the models' ability to simulate paracetamol absorption under fasted and fed conditions.
• To generate a baseline dataset supporting the validation of TIM systems for drug development.

Main Methods:

• An international ring study involving three laboratories using TIM-1 and five using tiny-TIM was conducted.
• Paracetamol, a well-characterized BCS Class I compound, was used to simulate oral administration of a 500 mg solution in healthy adults.
• In vitro simulations focused on paracetamol bioaccessibility, gastric and intestinal environmental parameters (pH, temperature, transit), and biopredictive metrics.

Main Results:

• Paracetamol bioaccessibility profiles demonstrated high repeatability and reproducibility, with pairwise f2 values exceeding 50.
• Maximum differences in total bioaccessible paracetamol were low, both within (0.9% for TIM-1, 2.8% for tiny-TIM) and between laboratories (3.4% for TIM-1, 5.9% for tiny-TIM).
• Both TIM models accurately predicted no food effect on total bioaccessibility and captured delayed Tmax, while maintaining repeatable physiological parameters mirroring in vivo patterns.

Conclusions:

• The TIM systems exhibit robust inter-laboratory reproducibility in simulating complex gastrointestinal conditions and drug absorption.
• These findings support the use of TIM systems as reliable in vitro models for drug product development, providing consistent and predictive measurements.
• The generated dataset offers a standardized, inter-laboratory baseline to aid regulatory submissions and enhance the interpretation of TIM experimental data.